Skip to main content

Sorafenib as a second-line treatment in metastatic renal cell carcinoma in Mexico: a prospective cohort study

Access & Citations

Citation counts are provided from Web of Science and CrossRef. The counts may vary by service, and are reliant on the availability of their data. Counts will update daily once available.